Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the record history.
    Difference
    0.0%
    Check dated 2026-04-16T11:00:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:12.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 on the Record History page.
    Difference
    0.0%
    Check dated 2026-03-11T15:28:59.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history. The funding notice and the previous revision v3.4.1 were removed from the history.
    Difference
    0.4%
    Check dated 2026-02-11T09:19:04.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operations. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:30:26.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    UI enhancements include a glossary toggle label, color-coded diffs for additions and deletions, and an updated revision tag (v3.4.0).
    Difference
    0.5%
    Check dated 2026-01-28T03:48:53.000Z thumbnail image

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.